| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 7,184 | 2,910 | ||
| Accounts receivable, net | 239 | - | ||
| Prepaid expense and other current assets | 1,437 | 1,680 | ||
| Subscription receivable | 3,087 | - | ||
| Total current assets | 11,947 | 4,590 | ||
| Other assets | 243 | 248 | ||
| Ppe | 93 | - | ||
| Nrx Segment | 23 | - | ||
| Dura Segment | 1 | - | ||
| Less accumulated depreciation | 24 | - | ||
| Furniture and equipment, net | 69 | - | ||
| Right-of-use assets, net-Nonrelated Party | 107 | - | ||
| Right-of-use assets, net-Related Party | 243 | - | ||
| Intangible assets, net | 1,777 | - | ||
| Goodwill | 610 | - | ||
| Total assets | 14,996 | 4,838 | ||
| Accounts payable | 4,257 | 3,630 | ||
| Accrued and other current liabilities | 9,875 | 9,974 | ||
| Accrued clinical site costs | 351 | 351 | ||
| Convertible note payable and accrued interest, current | 9,909 | 9,854 | ||
| Insurance loan payable | 152 | 378 | ||
| Warrant liabilities | 15,860 | 16,266 | ||
| Lease liability, short term-Nonrelated Party | 87 | - | ||
| Lease liability, short term-Related Party | 102 | - | ||
| Total current liabilities | 40,593 | 40,453 | ||
| Convertible note payable and accrued interest, long term | 0 | 0 | ||
| Lease liability, noncurrent-Nonrelated Party | 15 | - | ||
| Lease liability, noncurrent-Related Party | 143 | - | ||
| Total liabilities | 40,751 | 40,453 | ||
| Preferred stock-Nondesignated Preferred Stock | 0 | 0 | ||
| Preferred stock-Series AConvertible Preferred Stock | 0 | 0 | ||
| Common stock, 0.001 par value, 500,000,000 shares authorized 27,682,530 and 14,591,505 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 28 | 19 | ||
| Additional paid-in capital | 281,473 | 265,732 | ||
| Accumulated deficit | -307,256 | -301,366 | ||
| Total stockholders deficit | -25,755 | -35,615 | ||
| Total liabilities and stockholders' deficit | 14,996 | 4,838 | ||
NRX Pharmaceuticals, Inc. (NRXPW)
NRX Pharmaceuticals, Inc. (NRXPW)